TheLeadLeft

Private Debt Intelligence - 3/26/2018

Private Debt Fund Managers Are Optimistic Despite a Challenging Market As the private debt industry has matured, issues that have historically affected other alternative classes – high valuation and increased competition for transactions – have become increasingly prominent concerns. Almost half (49%) of private debt managers cite valuations as a key challenge facing the industry…

Spotlight on Healthcare – A Special Industry Report (First of a Series)

The private equity firm Platinum Equity announced last week they had offered to buy Johnson & Johnson’s blood glucose monitoring product for about $2.1 billion. The LifeScan Inc unit was one of several J&J businesses focused on diabetes devices. The medical products giant had apparently experienced declining revenues and squeezed margins in that arena and…

Leveraged Loan Insight & Analysis - 3/19/2018

Second lien issuance reaches $6.8B so far in 1Q18 Syndicated and privately placed second lien loan volume has reached US$6.8bn so far in 1Q18, which is not too far behind 4Q17’s volume of US$8.6bn. Issuers continue to rely on second lien facilities to maximize their leverage as 61% of the second liens tranches have been…